Resmed Inc Stock Analysis

ResMed Stock Analysis Notes

About 57.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.75. ResMed Inc recorded earning per share (EPS) of 6.04. The entity last dividend was issued on the 7th of February 2024. The firm had 2:1 split on the 31st of August 2010. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 8160 people. To find out more about ResMed Inc contact BE MBA at 858-836-5000 or learn more at https://www.resmed.com.

ResMed Inc Investment Alerts

ResMed Inc Upcoming and Recent Events

ResMed Largest EPS Surprises

View All Earnings Estimates

ResMed Thematic Classifications

ResMed Stock Institutional Investors

Note, although ResMed's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ResMed Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 27.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ResMed's market, we take the total number of its shares issued and multiply it by ResMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

ResMed Profitablity

The company has Net Profit Margin of 0.2 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.29 %, which entails that for every 100 dollars of revenue, it generated $0.29 of operating income.

Management Efficiency

ResMed Inc has Return on Asset of 0.1119 % which means that on every $100 spent on assets, it made $0.1119 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2166 %, implying that it generated $0.2166 on every 100 dollars invested. ResMed's management efficiency ratios could be used to measure how well ResMed manages its routine affairs as well as how well it operates its assets and liabilities. As of April 24, 2024, Return On Tangible Assets is expected to decline to 0.13. In addition to that, Return On Capital Employed is expected to decline to 0.14. At present, ResMed's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 477.5 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 42.6 M.

Technical Drivers

As of the 24th of April, ResMed holds the Semi Deviation of 1.82, coefficient of variation of 1692.18, and Risk Adjusted Performance of 0.0439. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ResMed, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We have collected data for nineteen technical drivers for ResMed Inc, which can be compared to its competitors. Please check ResMed Inc information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if ResMed Inc is priced some-what accurately, providing market reflects its current price of 183.78 per share. Given that ResMed has jensen alpha of (0.03), we recommend you to check out ResMed Inc's recent market performance to make sure the company can sustain itself at a future point.

ResMed Inc Price Movement Analysis

ResMed Inc Insider Trading Activities

ResMed Predictive Daily Indicators

ResMed Corporate Filings

ResMed Forecast Models

ResMed's time-series forecasting models are one of many ResMed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ResMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ResMed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ResMed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ResMed. By using and applying ResMed Stock analysis, traders can create a robust methodology for identifying ResMed entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ResMed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ResMed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ResMed Inc stock analysis indicators help investors evaluate how ResMed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ResMed shares will generate the highest return on investment. By understating and applying ResMed stock analysis, traders can identify ResMed position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.

Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.